Document Detail


Critical role of mTOR in calcineurin inhibitor-induced renal cancer progression.
MedLine Citation:
PMID:  22293493     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
Aninda Basu; Pallavi Banerjee; Soumitro Pal
Related Documents :
19588503 - Cancer and viral infections in immunocompromised individuals.
9881483 - Recombinant fv immunotoxins and fv fragments as novel agents for cancer therapy and dia...
17289293 - Colorectal cancer screening using fecal occult blood test and subsequent risk of colore...
Publication Detail:
Type:  Editorial; Research Support, N.I.H., Extramural     Date:  2012-02-15
Journal Detail:
Title:  Cell cycle (Georgetown, Tex.)     Volume:  11     ISSN:  1551-4005     ISO Abbreviation:  Cell Cycle     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-02-29     Completed Date:  2012-09-14     Revised Date:  2014-09-13    
Medline Journal Info:
Nlm Unique ID:  101137841     Medline TA:  Cell Cycle     Country:  United States    
Other Details:
Languages:  eng     Pagination:  633-4     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Calcineurin / antagonists & inhibitors*
Humans
Immunosuppressive Agents / adverse effects*,  therapeutic use
Kidney Neoplasms / chemically induced*,  genetics,  metabolism*
TOR Serine-Threonine Kinases / genetics,  metabolism*
Grant Support
ID/Acronym/Agency:
R01 CA131145/CA/NCI NIH HHS; R01 CA131145/CA/NCI NIH HHS; R01 CA131145-03/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Immunosuppressive Agents; EC 2.7.1.1/TOR Serine-Threonine Kinases; EC 3.1.3.16/Calcineurin
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  New Flavan and Benzil Isolated from Fissistigma latifolium.
Next Document:  The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent.